Canaccord Genuity Cuts Viking Therapeutics Price Target to $106 From $114
Canaccord Genuity maintained its Buy rating on Viking Therapeutics, according to the supplied ratings-action text.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.